veriNOS operations GmbH
Quick facts
Phase 3 pipeline
- VAS203 · Neurology
VAS203 is a nitric oxide synthase inhibitor that reduces nitric oxide production to protect against ischemic brain injury.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: